Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
JP Stocks

3544.T Satudora Holdings JPX closes JPY 836.00 18 Mar 2026: earnings outlook

March 18, 2026
4 min read
Share with:

The 3544.T stock closed at JPY 836.00 on 18 Mar 2026 as Satudora Holdings prepares to report earnings on 19 Mar 2026. We note a PE of 20.99, EPS JPY 39.59, and a market cap of JPY 11,451,408,525.00. Trading volume finished at 20,400.00 shares, near the 50-day average of 852.18, as investors position for guidance and margins.

3544.T stock: market snapshot and recent price action

Satudora Holdings (3544.T) closed at JPY 836.00 on the JPX on 18 Mar 2026, with a day range of JPY 831.00 to JPY 840.00. The share price sits above the 200-day average of JPY 835.37 but below the 50-day average of JPY 852.18, signalling short-term pressure. Year high is JPY 930.00 and year low is JPY 791.00, giving a defined trading band for near-term traders.

Sponsored

Earnings preview and what to watch for 3544.T stock

Satudora reports earnings on 19 Mar 2026; we expect focus on same-store sales, dispensing pharmacy margins and IT solutions revenue. Management guidance and pharmacy dispensing margins will drive the headline reaction. Watch for revisions to FY profit and cash flow commentary, which can move the stock given its current PE of 20.99.

Fundamental valuation and ratios for 3544.T stock

The balance of valuation shows mixed strengths and leverage. Key metrics: EPS JPY 39.59, PE 20.99, PB ratio 1.15, and dividend per share JPY 10.00. Debt to equity is high at 1.47, and interest coverage is 6.01, so leverage will matter if margins compress. Compared with the Healthcare sector PE of 23.62, Satudora trades modestly cheaper on PE.

Meyka AI rates 3544.T with a score out of 100 and technical signals

Meyka AI rates 3544.T with a score out of 100: 73.61 (Grade B+, Suggestion: BUY). This grade factors S&P 500 comparators, sector performance, financial growth, key metrics and analyst signals. Technicals show RSI 36.17 and ADX 45.72, indicating a strong trend but weak momentum. On balance, we see a cautious buy setup ahead of earnings.

Price forecasts, targets and scenarios for 3544.T stock

Meyka AI’s forecast model projects a 12-month target near JPY 888.50 and a monthly level of JPY 917.25. We set a conservative near-term target at JPY 820.00, a base case at JPY 888.50, and a bullish scenario near JPY 969.86 over three years. These targets reflect margin recovery in retail and IT growth assumptions.

Risks, catalysts and sector context for 3544.T stock

Key risks include leaning balance sheet metrics, compressed pharmacy margins, and slower retail traffic. Catalysts include stronger-than-expected dispensing margins, IT Solutions contract wins, and clearer capital allocation. The Healthcare sector shows muted YTD performance, so outperformance will require positive earnings surprise or clearer debt reduction plans.

Final Thoughts

Key takeaways on 3544.T stock: Satudora closed JPY 836.00 on 18 Mar 2026 ahead of earnings on 19 Mar 2026. Fundamentals show an EPS of JPY 39.59, PE 20.99, PB 1.15, and net leverage that warrants attention. Meyka AI’s forecast model projects a 12-month target of JPY 888.50, implying an upside of 6.28% versus the current price of JPY 836.00. We present a conservative target of JPY 820.00 and a bullish three-year scenario near JPY 969.86. These figures reflect our view that near-term stock movement will hinge on margin commentary and guidance. Forecasts are model-based projections and not guarantees. For background on earnings timing see the Investing.com earnings calendar and Satudora’s investor site at satudora-hd.co.jp. We use Meyka AI as an AI-powered market analysis platform to blend fundamentals and technicals for this earnings spotlight.

FAQs

When does Satudora Holdings report earnings and how might it affect 3544.T stock?

Satudora reports earnings on 19 Mar 2026. The report can move 3544.T stock on guidance for pharmacy margins, same-store sales, and IT revenue. A positive surprise may lift the stock by several percent.

What valuation metrics should investors watch for 3544.T stock?

Watch EPS JPY 39.59, PE 20.99, PB 1.15, and debt to equity 1.47. Changes to operating margin or debt guidance will shift the valuation multiple for 3544.T stock.

What is Meyka AI’s short-term forecast for 3544.T stock?

Meyka AI’s forecast model projects a 12-month target of JPY 888.50 for 3544.T stock, implying about 6.28% upside from JPY 836.00. Forecasts are model-based projections and not guarantees.

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
Meyka Newsletter
Get analyst ratings, AI forecasts, and market updates in your inbox every morning.
~15% average open rate and growing
Trusted by 10,000+ active investors
Free forever. No spam. Unsubscribe anytime.

What brings you to Meyka?

Pick what interests you most and we will get you started.

I'm here to read news

Find more articles like this one

I'm here to research stocks

Ask our AI about any stock

I'm here to track my Portfolio

Get daily updates and alerts (coming March 2026)